Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway

Journal of Experimental Medicine

Volumn 179, Issue 1, 1994, Pages 71-80

  Beasley, Debbie ^a   McGuiggin, Mary ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIAMINOPYRIMIDINE DERIVATIVE; 6 ANILINO 5,8 QUINOLINEQUINONE; AMINOGUANIDINE; ARGININE; BACTERIUM LIPOPOLYSACCHARIDE; CYCLIC GMP; CYTOKINE; DIPHENYLIODONIUM SALT; GUANYLATE CYCLASE; HEMOGLOBIN; INTERLEUKIN 2; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; METHYLENE BLUE; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TETRAHYDROBIOPTERIN;

ANIMAL CELL; AORTA; ARTICLE; CAVA VEIN; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; UMBILICAL ARTERY; VASCULAR SMOOTH MUSCLE;

AMINO ACID OXIDOREDUCTASES; AMINOQUINOLINES; ANIMAL; ARGININE; BASE SEQUENCE; CATECHOLAMINES; CELLS, CULTURED; CYCLIC GMP; DNA PRIMERS; ENZYME ACTIVATION; GUANYLATE CYCLASE; HUMAN; INTERFERON TYPE II; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; METHYLENE BLUE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; NITRITES; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0028157123     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.179.1.71     Document Type: Article

References (52)

1. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB (Fed. Am. Soc. Exp. Biol.) J. 6:3051.
2. Sakuma, I., D.J. Stuehr, S.S. Gross, C. Nathan, and R. Levi. 1988. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA. 85:8664.
3. Forstermann, U., J.S. Pollock, H.H.H.W. Schmidt, M. Heller, and F. Murad. 1991. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA. 88:1788.
4. Vallance, P., J. Collier, and S. Moncada. 1989. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 2:997.
5. Vallance, P., J. Collier, and S. Moncada. 1989. Nitric oxide synthesized from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovasc. Res. 23:1053.
6. Rees, D.D., R.M.J. Palmer, and S. Moncada. 1989. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA. 86:3375.
7. Beasley, D., J.H. Schwartz, and B.M. Brenner. 1991. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87:602.
8. Busse, R., and A. Mulsch. 1990. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS (Fed. Eur. Biochem. Soc.) Lett. 275:87.
9. Rees, D.D., S. Cellek, R.M.J. Palmer, and S. Monada. 1990. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into the endotoxin shock. Biochem. Biophys. Res. Commun. 173:541.
10. Beasley, D. 1990. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am. J. Physiol. 259:R38.
11. French, J.F., L.E. Lambert, and R.C. Dage. 1991. Nitric oxide synthase inhibitors inhibit interleukin-l/3-induced depression of vascular smooth muscle. J. Pharmacol. Exp. Ther. 259:260.
12. Libby, P., and K.V. O’Brien. 1983. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J. Cell Physiol. 115:217.
13. Ross, R., and B. Kariya. 1980. Morphogenesis of vascular smooth muscle in atherosclerosis and cell structure. In Handbook of Physiology. The Cardiovascular System, Section 2. D.F. Bohr, A.P. Somlyo, and H.Y. Sparks, editors. American Physiological Society, Bethesda, MD. 69.
14. Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannebaum. 1982. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal. Biochem. 126:131.
15. Chomczynski, P., and N. Sacchi. 1987. Single-step methods of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
16. Geller, D.A., C.J. Lowensten, R.A. Shapiro, A.K. Nussler, M. Di Silvio, S.C. Wang, D.K. Nakayama, R.L. Simmons, S. Snyder, and T.R. Billiar. 1993. Molecular cloning and expression of inducible nitric oxide synthase from human hepa-tocytes. Proc. Natl. Acad. Sci. USA. 90:3491.
17. Nunokawa, Y., N. Ishida, and S. Tanaka. 1993. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 191:89.
18. Beasley, D., and M. Eldridge. Interleukin-1/3 and tumor necrosis factor synergistically induce nitric oxide synthase in rat vascular smooth muscle cells. Am. J. Physiol. In press.
19. Gross, S.S., and R. Levi. 1992. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267:25722.
20. Hibbs, J.B.J., R.R. Taintor, and Z. Vavrin. 1987. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science (Wash. DC). 235:473.
21. Gross, S.S., D.J. Stuehr, K. Aisaka, E.A. Jaffe, R. Levi, and O.W. Griffith. 1990. Macrophage and endothelial cell nitric oxide synthesis: cell type-selective inhibition by NG-amino-arginine, NG-nitroarginine and NG-methylarginine. Biochem. Biophys. Res. Commun. 170:96.
22. Corbett, J.A., R.G. Tilton, K. Chang, K.S. Hasan, Y. Ido, J.L. Wang, M.A. Sweetland, J.R. Lancaster, Jr., and J.R. Williamson. 1992. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:552.
23. Marietta, M.A., P.S. Yoon, R. Iyengar, C.D. Leaf, and J.S. Wishnok. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 27:8706.
24. Hevel, J.M., K.A. White, and M.A. Marietta. 1991. Purification of the inducible murine macrophage nitric oxide synthase: Identification as a flavoprotein. J. Biol. Chem. 266:22789.
25. Bredt, D.S., C.D. Ferris, and S.H. Snyder. 1992. Nitric oxide synthase regulatory sites: phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium-calmodulin protein kinase; identification of flavin and calmodulin binding sites. J. Biol. Chem. 267:10976.
26. Stuehr, D.J., N.S. Kwon, and C.F. Nathan. 1990. FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem. Biophys. Res. Commun. 168:558.
27. Stuehr, D.J., O.A. Fasehun, N. Soo Kwon, S.S. Gross, J.A. Gonzalez, R. Levi, and C.F. Nathan. 1991. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyl-eneiodonium and its analogs. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:98.
28. Cross, A.R., and O.T.G. Jones. 1986. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem. J. 237:111.
29. Hancock, J.T., and O.T.G. Jones. 1987. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem. J. 242:103.
30. Hevel, J.M., and M.A. Marietta. 1992. Macrophage nitric oxide synthase: relationship between enzyme-bound tetrahydrobiopterin and synthase activity. Biochemistry. 31:7160.
31. Klatt, P., B. Heinzel, B. Mayer, E. Ambach, G. WernerFelmayer, H. Wachter, and E.R. Werner. 1992. Stimulation of human nitric oxide synthase by tetrahydrobiopterin and selective binding of the cofactor. FEBS (Fed. Eur. Biochem. Soc.) Lett. 305:160.
32. Gross, S.S., E.A. Jaffe, R. Levi, and R.G. Kilbourn. 1991. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem. Biophys. Res. Commun. 178:823.
33. Schmidt, K., E.R. Werner, B. Mayer, H. Wachter, and W.R. Kukovetz. 1992. Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem. J. 281:297.
34. Sakai, N., S. Kaufman, and S. Milstein. 1993. Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol. Pharmacol. 43:6.
35. Werner-Felmayer, B.G., E.R. Werner, D. Fuchs, A. Hausen, G. Reibnegger, and H. Wachter. 1990. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J. Exp. Med. 172:1599.
36. Bernhardt, J., M.R. Tschudi, Y. Dohi, I. Gut, B. Urwyler, F.R. Buhler, and T.F. Luscher. 1991. Release of nitric oxide from human vascular smooth muscle cells. Biochem. Biophys. Res. Comm. 180:907.
37. Martin, W., G.M. Villani, D. Jothianandan, and R.F. Furch-gott. 1985. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232:708.
38. Kontos, H.A., and E.P. Wei. 1993. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke. 24:427.
39. Gibson, Q.H., and F.J.W. Roughton. 1957. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J. Physiol. (Lond.). 136:507.
40. Janssens, S.P., A. Shimouchi, T. Quertermous, D.B. Bloch, and K.D. Bloch. 1992. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267:14519.
41. Junquero, D.C., T. Scott-Burden, V.B. Schini, and P.M. Van-houtte. 1992. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-j8l in human smooth muscle cells. J. Physiol. 454:451.
42. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 338:1557.
43. Hibbs, J.B., C. Westenfelder, R. Taintor, Z. Vavrin, C. Kab-litz, R. Baranowski, J.H. Ward, R.L. Menlove, M.P. McMurry, J. Kushner, and W.E. Samlowski. 1992. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89:867.
44. Ochoa, J.B., B. Curti, A.B. Peitzman, R.L. Simmons, T.R. Billiar, R. Hoffman, R. Rault, D.L. Longo, W.J. Urba, and A.C. Ochoa. 1992. Increased circulating nitrogen oxide after human tumor immunotherapy: correlation with toxic hemodynamic changes. J. Natl. Cancer. Inst. (Bethesda). 84:864.
45. Ochoa, J.B., A.O. Udekwu, T.R. Billiar, R.D. Curran, F.B. Cerra, R.L. Simmons, and A.B. Peitzman. 1991. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214:621.
46. Palmer, R.M.J., M.S. Hickery, I.G. Charles, S. Moncada, and M.T. Bayliss. 1993. Induction of nitric oxide synthase in human chondrocytes. Biochem. Biophys. Res. Commun. 193:398.
47. Cameron, M.L., D.L. Granger, J.B. Weinberg, W.J. Kozumbo, and H.S. Koren. 1990. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am. Rev. Respir. Dis. 142:1313.
48. Murray, H.W., and R.F. Teitelbaum. 1992. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165:513.
49. Padgett, E.L., and S.B. Pruett. 1992. Evaluation of nitrite production by human monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 186:775.
50. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358.
51. Sakai, N., and S. Milstien. 1993. Availability of tetrahydrobi-opterin is not a factor in the inability to detect nitric oxide production by human macrophages. Biochem. Biophys. Res. Commun. 193:378.
52. Denis, M. 1991. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49:380.